Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis

por Serritella, Anthony V., Shenoy, Niraj K.
Publicado 2023

Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings

por Hsieh, Po-Hung, Kacew, Alec J., Dreyer, Marie, Serritella, Anthony V., Knoebel, Randall W., Strohbehn, Garth W., Ratain, Mark J.
Publicado 2022

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advance...

por Mahalingam, Devalingam, Hanni, Salih, Serritella, Anthony V., Fountzilas, Christos, Michalek, Joel, Hernandez, Brian, Sarantopoulos, John, Datta, Paromitta, Romero, Ofelia, Pillai, Sureshkumar Mulampurath Achutan, Kuhn, John, Pollak, Michael, Thompson, Ian M.
Publicado 2023

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT...

por Mahalingam, Devalingam, Hanni, Salih, Serritella, Anthony V., Fountzilas, Christos, Michalek, Joel, Hernandez, Brian, Sarantopoulos, John, Datta, Paromitta, Romero, Ofelia, Achutan Pillai, Sureshkumar Mulampurath, Kuhn, John, Pollak, Michael, Thompson, Ian M.
Publicado 2023